7-(3-methyl-2H-indazol-5-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridin-1-amine;7-(3-methyl-2H-indazol-5-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridine;7-(3-methyl-2H-indazol-5-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridine-1-carbonitrile;1-methyl-7-[3-(trifluoromethyl)-2H-indazol-5-yl]-8,9,10,11-tetrahydro-2H-pyrazolo[4,3-a]phenanthridine

C90H75F3N22 — CID 157227647

IUPAC7-(3-methyl-2H-indazol-5-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridin-1-amine;7-(3-methyl-2H-indazol-5-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridine;7-(3-methyl-2H-indazol-5-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridine-1-carbonitrile;1-methyl-7-[3-(trifluoromethyl)-2H-indazol-5-yl]-8,9,10,11-tetrahydro-2H-pyrazolo[4,3-a]phenanthridine
SMILESCc1[nH]nc2ccc(-c3nc4ccc5[nH]nc(C#N)c5c4c4c3CCCC4)cc12.Cc1[nH]nc2ccc(-c3nc4ccc5[nH]nc(N)c5c4c4c3CCCC4)cc12.Cc1[nH]nc2ccc(-c3nc4ccc5[nH]ncc5c4c4c3CCCC4)cc12.Cc1[nH]nc2ccc3nc(-c4ccc5n[nH]c(C(F)(F)F)c5c4)c4c(c3c12)CCCC4
InChIInChI=1S/C23H18F3N5.C23H18N6.C22H20N6.C22H19N5/c1-11-19-18(30-28-11)9-8-17-20(19)13-4-2-3-5-14(13)21(27-17)12-6-7-16-15(10-12)22(31-29-16)23(24,25)26;1-12-16-10-13(6-7-17(16)27-26-12)23-15-5-3-2-4-14(15)21-18(25-23)8-9-19-22(21)20(11-24)29-28-19;1-11-15-10-12(6-7-16(15)26-25-11)21-14-5-3-2-4-13(14)19-17(24-21)8-9-18-20(19)22(23)28-27-18;1-12-16-10-13(6-7-18(16)27-25-12)22-15-5-3-2-4-14(15)21-17-11-23-26-19(17)8-9-20(21)24-22/h6-10H,2-5H2,1H3,(H,28,30)(H,29,31);6-10H,2-5H2,1H3,(H,26,27)(H,28,29);6-10H,2-5H2,1H3,(H,25,26)(H3,23,27,28);6-11H,2-5H2,1H3,(H,23,26)(H,25,27)
InChIKeyATSLRPNVSSSXKQ-UHFFFAOYSA-N
MW1521.74 g/mol
LogP19.84
Rot. Bonds4

About 7-(3-methyl-2H-indazol-5-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridin-1-amine;7-(3-methyl-2H-indazol-5-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridine;7-(3-methyl-2H-indazol-5-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridine-1-carbonitrile;1-methyl-7-[3-(trifluoromethyl)-2H-indazol-5-yl]-8,9,10,11-tetrahydro-2H-pyrazolo[4,3-a]phenanthridine

7-(3-methyl-2H-indazol-5-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridin-1-amine;7-(3-methyl-2H-indazol-5-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridine;7-(3-methyl-2H-indazol-5-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridine-1-carbonitrile;1-methyl-7-[3-(trifluoromethyl)-2H-indazol-5-yl]-8,9,10,11-tetrahydro-2H-pyrazolo[4,3-a]phenanthridine (PubChem CID 157227647) has the molecular formula C90H75F3N22 and a molecular weight of 1521.74 g/mol. Its IUPAC name is 7-(3-methyl-2H-indazol-5-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridin-1-amine;7-(3-methyl-2H-indazol-5-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridine;7-(3-methyl-2H-indazol-5-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridine-1-carbonitrile;1-methyl-7-[3-(trifluoromethyl)-2H-indazol-5-yl]-8,9,10,11-tetrahydro-2H-pyrazolo[4,3-a]phenanthridine.

Molecular Properties

Compound Name7-(3-methyl-2H-indazol-5-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridin-1-amine;7-(3-methyl-2H-indazol-5-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridine;7-(3-methyl-2H-indazol-5-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridine-1-carbonitrile;1-methyl-7-[3-(trifluoromethyl)-2H-indazol-5-yl]-8,9,10,11-tetrahydro-2H-pyrazolo[4,3-a]phenanthridine
PubChem CID157227647
Molecular FormulaC90H75F3N22
Molecular Weight1521.74 g/mol
Exact Mass1520.65
IUPAC Name7-(3-methyl-2H-indazol-5-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridin-1-amine;7-(3-methyl-2H-indazol-5-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridine;7-(3-methyl-2H-indazol-5-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridine-1-carbonitrile;1-methyl-7-[3-(trifluoromethyl)-2H-indazol-5-yl]-8,9,10,11-tetrahydro-2H-pyrazolo[4,3-a]phenanthridine
SMILESCc1[nH]nc2ccc(-c3nc4ccc5[nH]nc(C#N)c5c4c4c3CCCC4)cc12.Cc1[nH]nc2ccc(-c3nc4ccc5[nH]nc(N)c5c4c4c3CCCC4)cc12.Cc1[nH]nc2ccc(-c3nc4ccc5[nH]ncc5c4c4c3CCCC4)cc12.Cc1[nH]nc2ccc3nc(-c4ccc5n[nH]c(C(F)(F)F)c5c4)c4c(c3c12)CCCC4
InChIInChI=1S/C23H18F3N5.C23H18N6.C22H20N6.C22H19N5/c1-11-19-18(30-28-11)9-8-17-20(19)13-4-2-3-5-14(13)21(27-17)12-6-7-16-15(10-12)22(31-29-16)23(24,25)26;1-12-16-10-13(6-7-17(16)27-26-12)23-15-5-3-2-4-14(15)21-18(25-23)8-9-19-22(21)20(11-24)29-28-19;1-11-15-10-12(6-7-16(15)26-25-11)21-14-5-3-2-4-13(14)19-17(24-21)8-9-18-20(19)22(23)28-27-18;1-12-16-10-13(6-7-18(16)27-25-12)22-15-5-3-2-4-14(15)21-17-11-23-26-19(17)8-9-20(21)24-22/h6-10H,2-5H2,1H3,(H,28,30)(H,29,31);6-10H,2-5H2,1H3,(H,26,27)(H,28,29);6-10H,2-5H2,1H3,(H,25,26)(H3,23,27,28);6-11H,2-5H2,1H3,(H,23,26)(H,25,27)
InChIKeyATSLRPNVSSSXKQ-UHFFFAOYSA-N
XLogP19.84
TPSA330.81 Ų
H-Bond Donors9
H-Bond Acceptors14
Rotatable Bonds4
Heavy Atoms115
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001521.74
LogP ≤ 519.84
H-Bond Donors ≤ 59
H-Bond Acceptors ≤ 1014

Analyze 7-(3-methyl-2H-indazol-5-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridin-1-amine;7-(3-methyl-2H-indazol-5-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridine;7-(3-methyl-2H-indazol-5-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridine-1-carbonitrile;1-methyl-7-[3-(trifluoromethyl)-2H-indazol-5-yl]-8,9,10,11-tetrahydro-2H-pyrazolo[4,3-a]phenanthridine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 7-(3-methyl-2H-indazol-5-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridin-1-amine;7-(3-methyl-2H-indazol-5-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridine;7-(3-methyl-2H-indazol-5-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridine-1-carbonitrile;1-methyl-7-[3-(trifluoromethyl)-2H-indazol-5-yl]-8,9,10,11-tetrahydro-2H-pyrazolo[4,3-a]phenanthridine?
The IUPAC name of 7-(3-methyl-2H-indazol-5-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridin-1-amine;7-(3-methyl-2H-indazol-5-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridine;7-(3-methyl-2H-indazol-5-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridine-1-carbonitrile;1-methyl-7-[3-(trifluoromethyl)-2H-indazol-5-yl]-8,9,10,11-tetrahydro-2H-pyrazolo[4,3-a]phenanthridine (CID 157227647) is 7-(3-methyl-2H-indazol-5-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridin-1-amine;7-(3-methyl-2H-indazol-5-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridine;7-(3-methyl-2H-indazol-5-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridine-1-carbonitrile;1-methyl-7-[3-(trifluoromethyl)-2H-indazol-5-yl]-8,9,10,11-tetrahydro-2H-pyrazolo[4,3-a]phenanthridine.
What is the SMILES notation for 7-(3-methyl-2H-indazol-5-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridin-1-amine;7-(3-methyl-2H-indazol-5-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridine;7-(3-methyl-2H-indazol-5-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridine-1-carbonitrile;1-methyl-7-[3-(trifluoromethyl)-2H-indazol-5-yl]-8,9,10,11-tetrahydro-2H-pyrazolo[4,3-a]phenanthridine?
The canonical SMILES for 7-(3-methyl-2H-indazol-5-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridin-1-amine;7-(3-methyl-2H-indazol-5-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridine;7-(3-methyl-2H-indazol-5-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridine-1-carbonitrile;1-methyl-7-[3-(trifluoromethyl)-2H-indazol-5-yl]-8,9,10,11-tetrahydro-2H-pyrazolo[4,3-a]phenanthridine is Cc1[nH]nc2ccc(-c3nc4ccc5[nH]nc(C#N)c5c4c4c3CCCC4)cc12.Cc1[nH]nc2ccc(-c3nc4ccc5[nH]nc(N)c5c4c4c3CCCC4)cc12.Cc1[nH]nc2ccc(-c3nc4ccc5[nH]ncc5c4c4c3CCCC4)cc12.Cc1[nH]nc2ccc3nc(-c4ccc5n[nH]c(C(F)(F)F)c5c4)c4c(c3c12)CCCC4.
What is the InChIKey of 7-(3-methyl-2H-indazol-5-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridin-1-amine;7-(3-methyl-2H-indazol-5-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridine;7-(3-methyl-2H-indazol-5-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridine-1-carbonitrile;1-methyl-7-[3-(trifluoromethyl)-2H-indazol-5-yl]-8,9,10,11-tetrahydro-2H-pyrazolo[4,3-a]phenanthridine?
The InChIKey is ATSLRPNVSSSXKQ-UHFFFAOYSA-N. The full InChI is InChI=1S/C23H18F3N5.C23H18N6.C22H20N6.C22H19N5/c1-11-19-18(30-28-11)9-8-17-20(19)13-4-2-3-5-14(13)21(27-17)12-6-7-16-15(10-12)22(31-29-16)23(24,25)26;1-12-16-10-13(6-7-17(16)27-26-12)23-15-5-3-2-4-14(15)21-18(25-23)8-9-19-22(21)20(11-24)29-28-19;1-11-15-10-12(6-7-16(15)26-25-11)21-14-5-3-2-4-13(14)19-17(24-21)8-9-18-20(19)22(23)28-27-18;1-12-16-10-13(6-7-18(16)27-25-12)22-15-5-3-2-4-14(15)21-17-11-23-26-19(17)8-9-20(21)24-22/h6-10H,2-5H2,1H3,(H,28,30)(H,29,31);6-10H,2-5H2,1H3,(H,26,27)(H,28,29);6-10H,2-5H2,1H3,(H,25,26)(H3,23,27,28);6-11H,2-5H2,1H3,(H,23,26)(H,25,27).
What are the key properties of 7-(3-methyl-2H-indazol-5-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridin-1-amine;7-(3-methyl-2H-indazol-5-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridine;7-(3-methyl-2H-indazol-5-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridine-1-carbonitrile;1-methyl-7-[3-(trifluoromethyl)-2H-indazol-5-yl]-8,9,10,11-tetrahydro-2H-pyrazolo[4,3-a]phenanthridine?
7-(3-methyl-2H-indazol-5-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridin-1-amine;7-(3-methyl-2H-indazol-5-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridine;7-(3-methyl-2H-indazol-5-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridine-1-carbonitrile;1-methyl-7-[3-(trifluoromethyl)-2H-indazol-5-yl]-8,9,10,11-tetrahydro-2H-pyrazolo[4,3-a]phenanthridine has a molecular weight of 1521.74 g/mol, XLogP of 19.84, 4 rotatable bonds, 9 hydrogen bond donors, and 14 hydrogen bond acceptors.
Where does this data come from?
All data for 7-(3-methyl-2H-indazol-5-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridin-1-amine;7-(3-methyl-2H-indazol-5-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridine;7-(3-methyl-2H-indazol-5-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridine-1-carbonitrile;1-methyl-7-[3-(trifluoromethyl)-2H-indazol-5-yl]-8,9,10,11-tetrahydro-2H-pyrazolo[4,3-a]phenanthridine is sourced from PubChem (CID 157227647), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).